[Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].

about

Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities.

P2860

Q49887893-E438B357-223D-4326-92C3-A3F2D6CFED86

P2860

[Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].

Item

http://www.wikidata.org/entity/Q53232399

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

[Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].

@en

[Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].

@nl

type

Item

label

[Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].

@en

[Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].

@nl

prefLabel

[Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].

@en

[Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].

@nl

P1476

[Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].

@en

P2093

Hongyu Liu

http://www.w3.org/2001/XMLSchema#string

Jun Chen

http://www.w3.org/2001/XMLSchema#string

Yongwen Li

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and expression of human hepatocyte growth factor

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition

Targeting the tumor and its microenvironment by a dual-function decoy Met receptor

Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase

P304

625-634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3779/J.ISSN.1009-3419.2014.08.08

http://www.w3.org/2001/XMLSchema#string

P407

Chinese

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25130970

http://www.w3.org/2001/XMLSchema#string

P932

6000362

http://www.w3.org/2001/XMLSchema#string

[Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].

about

P2860

P2860

[Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932